406
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Therapeutic cancer vaccines: a long and winding road to success

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Leonid Dubrovsky, Tao Dao, Ron S Gejman, Elliott J Brea, Aaron Y Chang, Claire Y Oh, Emily Casey, Dmitry Pankov & David A Scheinberg. (2016) T cell receptor mimic antibodies for cancer therapy. OncoImmunology 5:1.
Read now
Constantin N Baxevanis, Michael Papamichail & Sonia A Perez. (2014) Immunologic biomarkers in prostate cancer. Human Vaccines & Immunotherapeutics 10:5, pages 1244-1247.
Read now

Articles from other publishers (9)

Colby S. Shemesh, Joy C. Hsu, Iraj Hosseini, Ben-Quan Shen, Anand Rotte, Patrick Twomey, Sandhya Girish & Benjamin Wu. (2021) Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities. Molecular Therapy 29:2, pages 555-570.
Crossref
Constantin N. Baxevanis, Sotirios P. Fortis, Alexandros Ardavanis & Sonia A. Perez. (2020) Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design. Cancers 12:10, pages 2908.
Crossref
Fengzhen Mo, Dabing Xue, Siliang Duan, Aiqun Liu, Xiaomei Yang, Xiaoqiong Hou & Xiaoling Lu. (2019) Novel fusion cells derived from tumor cells expressing the heterologous α-galactose epitope and dendritic cells effectively target cancer. Vaccine 37:7, pages 926-936.
Crossref
M.M. Strioga & N.T. Dobrovolskiene. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines 43 64 .
Sean M. Geary, Qiaohong Hu, Vijaya B. Joshi, Ned B. Bowden & Aliasger K. Salem. (2015) Diaminosulfide based polymer microparticles as cancer vaccine delivery systems. Journal of Controlled Release 220, pages 682-690.
Crossref
Eleftheria A. Anastasopoulou, Ioannis F. Voutsas, Theodora Keramitsoglou, Cécile Gouttefangeas, Hubert Kalbacher, Anastasios Thanos, Michael Papamichail, Sonia A. Perez & Constantin N. Baxevanis. (2015) A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit. Cancer Immunology, Immunotherapy 64:9, pages 1123-1136.
Crossref
Maxwell Omabe, Shahid Ahmed, Amer Sami, Yufeng Xie, Min Tao & Jim Xiang. (2015) HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy. World Journal of Vaccines 05:02, pages 106-128.
Crossref
Ronald Rooke. (2014) Can calcium signaling be harnessed for cancer immunotherapy?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:10, pages 2334-2340.
Crossref
Nora Berois & Eduardo Osinaga. (2014) Glycobiology of Neuroblastoma: Impact on Tumor Behavior, Prognosis, and Therapeutic Strategies. Frontiers in Oncology 4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.